{"generic":"Ivabradine","drugs":["Corlanor","Ivabradine"],"mono":{"0":{"id":"jyo8s0","title":"Generic Names","mono":"Ivabradine"},"1":{"id":"jyo8s1","title":"Dosing and Indications","sub":[{"id":"jyo8s1b4","title":"Adult Dosing","mono":"<ul><li><b>Heart failure, chronic:<\/b> Initial, 5 mg ORALLY twice daily; after 2 weeks, adjust based on heart rate; for resting rate greater than 60 beats per minute (bpm), increase dose by 2.5 mg twice daily; for 50 to 60 bpm, continue current dose; for less than 50 bpm or for signs or symptoms of bradycardia, decrease dose by 2.5 mg twice daily; MAX dose, 7.5 mg twice daily<\/li><li><b>Stable angina, chronic, In combination with beta-blocker therapy:<\/b> 5 mg ORALLY twice daily for 2 months, then increase to 7.5 mg ORALLY twice daily if heart rate is at least 50 beats per minute; used in combination with atenolol 50 mg ORALLY once daily (study dosing)<\/li><\/ul>"},{"id":"jyo8s1b5","title":"Pediatric Dosing","mono":"Safety and efficacy not established in pediatric patients "},{"id":"jyo8s1b6","title":"Dose Adjustments","mono":"<ul><li><b>Renal impairment, CrCl greater than 15 mL\/min:<\/b> No adjustment required<\/li><li><b>Hepatic impairment, mild to moderate (Child-Pugh A and B):<\/b> No adjustment required<\/li><li><b>Hepatic impairment, severe (Child-Pugh C):<\/b> Use contraindicated<\/li><li><b>History of conduction defects or bradycardia that could lead to hemodynamic compromise:<\/b> Initiate at 2.5 mg orally twice daily and titrate based on heart rate.<\/li><\/ul>"},{"id":"jyo8s1b7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Heart failure, chronic<br\/><b>Non-FDA Labeled Indications<\/b><br\/>Stable angina, chronic, In combination with beta-blocker therapy<br\/>"}]},"3":{"id":"jyo8s3","title":"Contraindications\/Warnings","sub":[{"id":"jyo8s3b9","title":"Contraindications","mono":"<ul><li>Acute decompensated heart failure<\/li><li>Concomitant use with strong CYP3A4 inhibitors<\/li><li>Pacemaker dependent<\/li><li>Resting heart rate below 60 beats per minute before treatment<\/li><li>Severe hepatic impairment<\/li><li>Severe hypotension (less than 90\/50 mmHg)<\/li><li>Sick sinus syndrome, sinoatrial block, or third-degree atrioventricular block, except in presence of functioning demand pacemaker<\/li><\/ul>"},{"id":"jyo8s3b10","title":"Precautions","mono":"<ul><li>Cardiovascular:<\/li><li>-- Avoid use with second-degree AV block in patients without a functioning demand pacemaker<\/li><li>-- Use not recommended in patients with demand pacemakers set to 60 or greater beats per minutes<\/li><li>-- Increased risk of atrial fibrillation; monitoring recommended; discontinue use if develops<\/li><li>-- Bradycardia has been reported; increased risk with sinus node dysfunction, conduction defects, ventricular dyssynchrony; monitoring recommended if used with other negative chronotropic agents<\/li><li>-- Sinus arrest and heart block have been reported<\/li><li>Reproductive:<\/li><li>-- Appropriate contraception is required with use in women of childbearing potential<\/li><li>Concomitant use:<\/li><li>-- Avoid use with verapamil or diltiazem<\/li><li>-- Avoid use with CYP3A4 inducers or moderate CYP3A4 inhibitors<\/li><\/ul>"},{"id":"jyo8s3b11","title":"Pregnancy Category","mono":"Fetal risk cannot be ruled out. (TH)<br\/>"},{"id":"jyo8s3b12","title":"Breast Feeding","mono":"Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"4":{"id":"jyo8s4","title":"Drug Interactions","sub":[{"id":"jyo8s4b13","title":"Contraindicated","mono":"<ul><li>Amifampridine (theoretical)<\/li><li>Aprepitant (theoretical)<\/li><li>Atazanavir (theoretical)<\/li><li>Bepridil (theoretical)<\/li><li>Boceprevir (theoretical)<\/li><li>Cisapride (theoretical)<\/li><li>Clarithromycin (theoretical)<\/li><li>Cobicistat (theoretical)<\/li><li>Conivaptan (theoretical)<\/li><li>Delavirdine (theoretical)<\/li><li>Dronedarone (theoretical)<\/li><li>Fluconazole (theoretical)<\/li><li>Fosaprepitant (theoretical)<\/li><li>Idelalisib (theoretical)<\/li><li>Imatinib (theoretical)<\/li><li>Indinavir (theoretical)<\/li><li>Itraconazole (theoretical)<\/li><li>Josamycin (theoretical)<\/li><li>Ketoconazole (theoretical)<\/li><li>Lopinavir (theoretical)<\/li><li>Mesoridazine (established)<\/li><li>Nefazodone (theoretical)<\/li><li>Nelfinavir (theoretical)<\/li><li>Pimozide (theoretical)<\/li><li>Piperaquine (theoretical)<\/li><li>Posaconazole (theoretical)<\/li><li>Ritonavir (theoretical)<\/li><li>Saquinavir (theoretical)<\/li><li>Sparfloxacin (theoretical)<\/li><li>Telaprevir (theoretical)<\/li><li>Telithromycin (theoretical)<\/li><li>Terfenadine (theoretical)<\/li><li>Thioridazine (theoretical)<\/li><li>Tipranavir (theoretical)<\/li><li>Voriconazole (theoretical)<\/li><li>Ziprasidone (theoretical)<\/li><\/ul>"},{"id":"jyo8s4b14","title":"Major","mono":"<ul><li>Alfuzosin (theoretical)<\/li><li>Amiodarone (theoretical)<\/li><li>Amitriptyline (theoretical)<\/li><li>Anagrelide (theoretical)<\/li><li>Apomorphine (theoretical)<\/li><li>Aprobarbital (theoretical)<\/li><li>Aripiprazole (theoretical)<\/li><li>Armodafinil (theoretical)<\/li><li>Arsenic Trioxide (theoretical)<\/li><li>Asenapine (theoretical)<\/li><li>Astemizole (theoretical)<\/li><li>Azithromycin (theoretical)<\/li><li>Bedaquiline (theoretical)<\/li><li>Bosentan (theoretical)<\/li><li>Buserelin (theoretical)<\/li><li>Butabarbital (theoretical)<\/li><li>Butalbital (theoretical)<\/li><li>Carbamazepine (theoretical)<\/li><li>Ceritinib (theoretical)<\/li><li>Chloroquine (theoretical)<\/li><li>Chlorpromazine (theoretical)<\/li><li>Ciprofloxacin (theoretical)<\/li><li>Citalopram (theoretical)<\/li><li>Clomipramine (theoretical)<\/li><li>Clozapine (theoretical)<\/li><li>Crizotinib (theoretical)<\/li><li>Cyclobenzaprine (theoretical)<\/li><li>Dabrafenib (theoretical)<\/li><li>Darunavir (theoretical)<\/li><li>Dasatinib (theoretical)<\/li><li>Degarelix (theoretical)<\/li><li>Delamanid (theoretical)<\/li><li>Desipramine (theoretical)<\/li><li>Deslorelin (theoretical)<\/li><li>Dexamethasone (theoretical)<\/li><li>Diltiazem (theoretical)<\/li><li>Disopyramide (theoretical)<\/li><li>Dofetilide (theoretical)<\/li><li>Dolasetron (theoretical)<\/li><li>Domperidone (theoretical)<\/li><li>Donepezil (probable)<\/li><li>Doxepin (theoretical)<\/li><li>Droperidol (theoretical)<\/li><li>Ebastine (theoretical)<\/li><li>Efavirenz (theoretical)<\/li><li>Enzalutamide (theoretical)<\/li><li>Eribulin (theoretical)<\/li><li>Erythromycin (theoretical)<\/li><li>Escitalopram (theoretical)<\/li><li>Eslicarbazepine Acetate (theoretical)<\/li><li>Etravirine (theoretical)<\/li><li>Famotidine (theoretical)<\/li><li>Felbamate (theoretical)<\/li><li>Fingolimod (theoretical)<\/li><li>Flecainide (theoretical)<\/li><li>Fluoxetine (theoretical)<\/li><li>Formoterol (theoretical)<\/li><li>Foscarnet (theoretical)<\/li><li>Fosphenytoin (theoretical)<\/li><li>Galantamine (theoretical)<\/li><li>Gatifloxacin (theoretical)<\/li><li>Gemifloxacin (theoretical)<\/li><li>Gonadorelin (theoretical)<\/li><li>Goserelin (theoretical)<\/li><li>Granisetron (theoretical)<\/li><li>Halofantrine (theoretical)<\/li><li>Haloperidol (theoretical)<\/li><li>Histrelin (theoretical)<\/li><li>Hydroquinidine (theoretical)<\/li><li>Hydroxychloroquine (probable)<\/li><li>Ibutilide (theoretical)<\/li><li>Iloperidone (theoretical)<\/li><li>Imipramine (theoretical)<\/li><li>Lapatinib (theoretical)<\/li><li>Leuprolide (theoretical)<\/li><li>Levofloxacin (theoretical)<\/li><li>Lumefantrine (theoretical)<\/li><li>Mefloquine (theoretical)<\/li><li>Mephobarbital (theoretical)<\/li><li>Methadone (theoretical)<\/li><li>Methohexital (theoretical)<\/li><li>Metronidazole (theoretical)<\/li><li>Mifepristone (theoretical)<\/li><li>Mitotane (theoretical)<\/li><li>Mizolastine (theoretical)<\/li><li>Modafinil (theoretical)<\/li><li>Moxifloxacin (theoretical)<\/li><li>Nafarelin (theoretical)<\/li><li>Nafcillin (theoretical)<\/li><li>Nevirapine (theoretical)<\/li><li>Nilotinib (theoretical)<\/li><li>Norfloxacin (theoretical)<\/li><li>Octreotide (theoretical)<\/li><li>Olanzapine (theoretical)<\/li><li>Ondansetron (theoretical)<\/li><li>Oxcarbazepine (theoretical)<\/li><li>Paliperidone (theoretical)<\/li><li>Panobinostat (theoretical)<\/li><li>Paroxetine (theoretical)<\/li><li>Pasireotide (theoretical)<\/li><li>Pazopanib (theoretical)<\/li><li>Pentamidine (theoretical)<\/li><li>Pentobarbital (theoretical)<\/li><li>Perflutren Lipid Microsphere (theoretical)<\/li><li>Perphenazine (theoretical)<\/li><li>Phenobarbital (theoretical)<\/li><li>Phenytoin (theoretical)<\/li><li>Primidone (theoretical)<\/li><li>Probucol (theoretical)<\/li><li>Procainamide (theoretical)<\/li><li>Prochlorperazine (theoretical)<\/li><li>Promethazine (theoretical)<\/li><li>Propafenone (theoretical)<\/li><li>Protriptyline (theoretical)<\/li><li>Quetiapine (theoretical)<\/li><li>Quinidine (theoretical)<\/li><li>Quinine (theoretical)<\/li><li>Ranolazine (theoretical)<\/li><li>Rifabutin (theoretical)<\/li><li>Rifampin (theoretical)<\/li><li>Rifapentine (theoretical)<\/li><li>Rilpivirine (theoretical)<\/li><li>Risperidone (theoretical)<\/li><li>Secobarbital (theoretical)<\/li><li>Sertindole (theoretical)<\/li><li>Sevoflurane (theoretical)<\/li><li>Siltuximab (theoretical)<\/li><li>Sodium Phosphate (theoretical)<\/li><li>Sodium Phosphate, Dibasic (theoretical)<\/li><li>Sodium Phosphate, Monobasic (theoretical)<\/li><li>Solifenacin (theoretical)<\/li><li>Sorafenib (theoretical)<\/li><li>Sotalol (theoretical)<\/li><li>St John's Wort (theoretical)<\/li><li>Sunitinib (theoretical)<\/li><li>Tacrolimus (theoretical)<\/li><li>Tamoxifen (theoretical)<\/li><li>Telavancin (theoretical)<\/li><li>Tetrabenazine (theoretical)<\/li><li>Thiopental (theoretical)<\/li><li>Tizanidine (theoretical)<\/li><li>Tolterodine (theoretical)<\/li><li>Toremifene (theoretical)<\/li><li>Trazodone (theoretical)<\/li><li>Trimipramine (theoretical)<\/li><li>Triptorelin (theoretical)<\/li><li>Vandetanib (theoretical)<\/li><li>Vardenafil (theoretical)<\/li><li>Vemurafenib (theoretical)<\/li><li>Venlafaxine (theoretical)<\/li><li>Verapamil (theoretical)<\/li><li>Vilanterol (theoretical)<\/li><li>Vinflunine (theoretical)<\/li><li>Vorinostat (theoretical)<\/li><\/ul>"}]},"5":{"id":"jyo8s5","title":"Adverse Effects","mono":"<b>Common<\/b><br\/><b>Cardiovascular:<\/b>Atrial fibrillation (8.3%), Bradyarrhythmia (10%)<br\/>"},"6":{"id":"jyo8s6","title":"Drug Name Info","sub":{"0":{"id":"jyo8s6b17","title":"US Trade Names","mono":"Corlanor<br\/>"},"2":{"id":"jyo8s6b19","title":"Class","mono":"Cardiovascular Agent<br\/>"},"3":{"id":"jyo8s6b20","title":"Regulatory Status","mono":"RX<br\/>"},"4":{"id":"jyo8s6b21","title":"Generic Availability","mono":"No<br\/>"}}},"7":{"id":"jyo8s7","title":"Mechanism Of Action","mono":"Ivabradine reduces spontaneous pacemaker activity at the cardiac sinus node by blocking the hyperpolarization-activated cyclic nucleotide-gated (HCN) channel to selectively inhibit I(f)-current, thus reducing the heart rate. Ventricular repolarization and myocardial contractility are not affected.<br\/>"},"8":{"id":"jyo8s8","title":"Pharmacokinetics","sub":[{"id":"jyo8s8b23","title":"Absorption","mono":"<ul><li>Tmax, oral: 1 hour<\/li><li>Bioavailability, oral: 40%<\/li><li>Effect of food: Absorption delayed 1 hour; exposure increased 20% to 40%<\/li><\/ul>"},{"id":"jyo8s8b24","title":"Distribution","mono":"<ul><li>Protein binding: 70%<\/li><li>Vd: 100 L<\/li><\/ul>"},{"id":"jyo8s8b25","title":"Metabolism","mono":"<ul><li>Intestines: Extensive, via CYP3A4-mediated oxidation<\/li><li>Liver: Extensive, via CYP3A4-mediated oxidation<\/li><li>N-desmethylated derivative (S 18982): Major, active<\/li><li>Substrate of CYP3A4<\/li><\/ul>"},{"id":"jyo8s8b26","title":"Excretion","mono":"<ul><li>Fecal: Some excretion of metabolites<\/li><li>Renal: 4%, unchanged<\/li><li>Renal clearance: 4.2 L\/hr<\/li><li>Total body clearance: 24 L\/hr<\/li><\/ul>"},{"id":"jyo8s8b27","title":"Elimination Half Life","mono":"6 hours <br\/>"}]},"9":{"id":"jyo8s9","title":"Administration","mono":"<b>Oral<\/b><br\/>Take with meals.<br\/>"},"11":{"id":"jyo8s11","title":"How Supplied","mono":"<b>Corlanor<\/b><br\/>Oral Tablet: 5 MG, 7.5 MG<br\/>"},"13":{"id":"jyo8s13","title":"Clinical Teaching","mono":"<ul><li>Advise patient to report symptoms of bradycardia or atrial fibrillation.<\/li><li>Recommend female patient avoid pregnancy during therapy.<\/li><li>Warn patient to avoid driving or other activities where sudden changes in light intensity may occur until drug effects are realized, due to potential for luminous phenomena (phosphenes).<\/li><li>Instruct patient to take drug with food to increase absorption.<\/li><li>Counsel patient to avoid grapefruit juice.<\/li><\/ul>"}}}